SELECTIVE IgM DEPLETION PROLONGS ORGAN SURVIVAL IN AN EX VIVO MODEL OF PIG-TO-HUMAN XENOTRANSPLANTATION1,2
- 15 July 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 62 (1) , 5-12
- https://doi.org/10.1097/00007890-199607150-00002
Abstract
In the pig-to-primate model, xenograft hyperacute rejection (HAR) is mediated by antibody and complement. Previous studies have implicated xenoreactive IgM natural antibody (nAb) as the predominant immunoglobulin involved in HAR. To further evaluate the role of IgM, we selectively reduced IgM levels in human blood, without changing IgG and IgA levels, and then used this blood to perfuse porcine hearts ex vivo. Specific IgM depletion was accomplished with an immunoabsorption column containing sheep anti-human IgM(μ-chain specific) conjugated to Sepharose beads. Human blood was separated into plasma and cellular components. For control experiments, those components were unmodified and recombined in the perfusion system. For experiments with IgM reduced blood, the plasma was passed through the IgM column. Immunoabsorption resulted in ≈90% reduction in xenoreactive IgM levels, as measured by ELISA. Porcine hearts perfused with unmodified human blood survived 25±5.6 min (n=5). Porcine hearts perfused with human blood containing reduced levels of IgM survived 229±45.2 min (n=4;PP=0.01), and not with IgG nAb levels (r=-0.21;P=0.62). The ability of plasma from IgM-depleted blood to elicit complement activation, measured by iC3b binding to porcine aortic endothelial cells in vitro, was also strongly associated with IgM xenoreactive nAb levels (r=0.92; P.Keywords
This publication has 19 references indexed in Scilit:
- Antibody Removal by Column Immunoabsorption Prevents Tissue Injury in an Ex Vivo Model of Pig-to-Human Xenograft Hyperacute RejectionJournal of Surgical Research, 1995
- Removal Of Baboon And Human Antiporcine Igg And Igm Natural Antibodies By ImmunoadsorptionTransplantation, 1995
- Human xenoreactive natural antibodies of the IgM isotype activate pig endothelial cellsXenotransplantation, 1994
- THE ROLE OF ANTI-PIG ANTIBODY IN PIG-TO-BABOON CARDIAC XENOTRANSPLANT REJECTION1Transplantation, 1994
- The complement system in xenotransplantationImmunopharmacology, 1992
- THE ROLE OF NATURAL ANTIBODIES IN THE ACTIVATION OF XENOGENIC ENDOTHELIAL CELLSTransplantation, 1991
- The role of C5a and antibody in the release of heparan sulfate from endothelial cellsEuropean Journal of Immunology, 1991
- IMMUNOPATHOLOGY OF HYPERACUTE XENOGRAFT REJECTION IN A SWINE-TO-PRIMATE MODELTransplantation, 1991
- Transplantation of discordant xenografts: a review of progressImmunology Today, 1990
- XENOGENEIC TRANSPLANTATIONTransplantation, 1988